With year-to-date gains of 2300%, 3300% and 3400%, respectively, the three stocks that are the focus of today’s article – two biotechs and a molecular… Read More »With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?
When it comes to cheap stocks, the author of today’s article notes that “beyond the risks there is potential for big reward.” As such, she… Read More »10 Under $10: “Cheap Stocks With Rich Paths Ahead”
Regarding investor behavior amid the current market volatility, the author of today’s article observes that “A select group remains ready to take on some risk,… Read More »3 “Strong Buy” Pharma Stocks With Significant Upside Potential – And Catalysts Around The Corner